Neovasc Provides Highlights from EuroPCR; Symposium Generates Increased Interest in Reducer

VANCOUVER, May 25, 2018 -- (Healthcare Sales & Marketing Network) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, t... Devices, Interventional, Cardiology Neovasc, Tiara, Neovasc Reducer, angina pectoris, refractory angina
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news